Skip to main content

Table 2 Main characteristics of randomized controlled trials included in the meta-analysis

From: Posterior pericardiotomy to prevent new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis of 10 randomized controlled trials

Study ID Area Operation period Study design Surgery type No. of patients (PP/control) Age (years) Male (%) Cross-clamp time (min) CPB time (min)
PP Control PP (%) Control (%) PP Control PP Control
Kaya [34] Turkey 2012.3–2013.1 RCT CABG 63(30/33) 57 ± 10 59 ± 11 76.67 87.88 43 ± 16 46 ± 21 80 ± 26 86 ± 27
Kaygin [33] Turkey 2009.8–2011.2 RCT CABG 425(213/212) 59 ± 11 59 ± 11 50.23 49.53  > 50  > 50  > 80  > 80
Fawzy [35] Egypt 2010.6–2012.5 RCT CABG 200(100/100) 54 ± 9 56 ± 10 64.00 68.00 55 ± 21 59 ± 17 89 ± 29 87 ± 23
Zhao [29] China 2012.1–2013.1 RCT CABG 458(228/230) 54 ± 16 56 ± 18 60.53 54.35 67 ± 29 62 ± 23 110 ± 46 103 ± 51
Kuralay [18] Turkey 1996.6–1997.6 RCT CABG 200(100/100) 57 ± 12 61 ± 8 77 73 36 ± 12 43 ± 9 48 ± 5 51 ± 4
Asimakopoulos [32] UK NR RCT CABG 100(50/50) 60 ± 9 60 ± 9 NR NR 35 33 66 62
Ekim [20] Turkey 2003.10–2005.7 RCT CABG 100(50/50) 59 ± 9 60 ± 3 66 64 63 ± 19 62 ± 12 89 ± 21 87 ± 26
Farsak [19] Turkey 2000.4–2001.10 RCT CABG 150(75/75) 64 ± 9 63 ± 5 36 32 35 ± 11 40 ± 9 58 ± 6 61 ± 9
Kongmalai [22] Thailand 2013.8–2013.12 RCT CABG 20(10/10) 65 ± 13 59 ± 5 50.00 50.00 84 ± 38 107 ± 39 128 ± 49 152 ± 45
Arbatli [21] Turkey 2000.5–2000.12 RCT CABG 113(54/59) 62 ± 8 60 ± 9 83.33 74.58 58 ± 17 60 ± 19 117 ± 32 112 ± 35
  1. CABG, coronary artery bypass grafting; POAF, postoperative atrial fibrillation; ICU, intensive care unit; RCT, randomized controlled trial; NR, not reported; CPB, cardiopulmonary bypass; IABP, intra-aortic balloon pump